Transformed Mycosis Fungoides
📧 Sign up to get email alerts when something new happens for Transformed Mycosis Fungoides.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas [Phase 1]
Phase 1 trial update evaluating the combination of romidepsin and parsaclisib for relapsed or refractory T-cell lymphomas; the study status …
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Mechlorethamine Induced Contact Dermatitis Avoidance Study [Phase 2]
Phase 2 clinical trial assessing avoidance of mechlorethamine–induced contact dermatitis in patients with cutaneous T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides [Phase 1]
A multicentre Phase I trial from the University of Cologne evaluates engineered CD30-targeted T cells for relapsed or refractory primary cut…